文献速递胃肠外科围术期管理与 ERAS

腹腔镜与开腹原发结肠切除对后续CRS/HIPEC远期结局的影响

The impact of laparoscopic vs open primary colon resection on long-term outcomes after subsequent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for metachronous peritoneal metastasis.
PubMed 文献 · Surg Endosc · 2025-05-16

本研究基于前瞻性腹膜表面恶性肿瘤数据库,纳入2015至2022年因结直肠癌腹膜转移接受CRS/HIPEC且此前曾行结肠切除的159例患者,按原发结肠切除方式分为开腹组101例与腹腔镜组58例。腹腔镜组上段空肠受累比例更高(45.5% vs 22%,p=0.004),手术时间更短(4.1 vs 4.69小时,p=0.004);腹腔镜组中位无病生存期25.9个月(95%CI 0-68.1)优于开腹组9.9个月(95%CI 1.4-12.6)(p<0.001),多因素分析显示原发结肠切除方式与DFS独立相关。

要点

  • 原发结肠切除采用腹腔镜者后续CRS/HIPEC后DFS可能更优。
  • 腹腔镜组上段空肠受累比例更高,手术时间更短。
  • 原发结肠切除方式是DFS的独立相关因素。

核心结论

  • 腹腔镜结肠切除后行CRS/HIPEC治疗异时性腹膜转移可能与有利的围手术期和生存结局相关。

研究设计与样本

  • 回顾性队列研究,从2015至2022年前瞻性腹膜表面恶性肿瘤数据库纳入159例既往因结直肠癌行结肠切除、后因腹膜转移接受CRS/HIPEC的患者。
  • 按原发结肠切除方式分为开腹组101例和腹腔镜组58例,比较围手术期、30天结局及生存结局。

主要发现

  • 两组人口学特征和合并症相似,原发结肠切除时TNM分期及CRS/HIPEC时PCI评分相似。
  • 腹腔镜组上段空肠受累比例高于开腹组(45.5% vs 22%,p=0.004),平均手术时间短于开腹组(4.1 vs 4.69小时,p=0.004)。
  • 腹腔镜组与开腹组估计中位无病生存期分别为25.9个月(95%CI 0-68.1)和9.9个月(95%CI 1.4-12.6),p<0.001。
  • 多因素分析中,原发结肠切除的手术方式与DFS独立相关。

临床怎么用

  • 对于既往行腹腔镜结肠切除的结直肠癌腹膜转移患者,后续CRS/HIPEC的围手术期和生存结局可能更有利。
  • 原发结肠切除方式可作为后续CRS/HIPEC预后评估的参考因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several factors have been known to correlate with the early and long-term outcomes of patients undergoing CRS/HIPEC. However, the relation between surgical approach (open vs laparoscopic colectomy) at the index colectomy and oncological outcomes following CRS/HIPEC have not been studied. METHODS: Patients who underwent CRS/HIPEC after previous colectomy for colorectal cancer with peritoneal metastases from 2015 to 2022 were identified from a prospectively maintained database of peritoneal surface malignancies and were divided into two groups according to the primary colectomy approach open or laparoscopic colectomy. Operative and 30-day outcomes were compared between groups, as well as survival outcomes. RESULTS: A total of 159 patients met inclusion criteria, of those 101 patients were in the open group and 58 patients were in the laparoscopic group. Both groups had similar demographics and comorbidities. TNM staging at index colectomy was similar between the groups as well as peritoneal cancer index (PCI) score for CRS/HIPEC surgery; however, there was more upper jejunal disease involvement in the laparoscopic group compared with the open group (45.5% vs. 22%, p = 0.004) and shorter mean duration of surgery (4.1 vs. 4.69 [hour], p = 0.004). For the laparoscopic and open colectomy groups, respectively, estimated median disease-free survival (DFS) was 25.9 months (95%CI 0-68.1) vs. 9.9 months (95%CI 1.4-12.6) (p < 0.001). In a multivariable analysis the surgical approach of the index colectomy was independently associated with DFS. CONCLUSION: Performing CRS HIPEC for metachronous peritoneal metastasis following laparoscopic colectomy may be associated with favorable perioperative and survival outcomes.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Nevo Y, Assaf D, Jacover A, et al. The impact of laparoscopic vs open primary colon resection on long-term outcomes after subsequent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for metachronous peritoneal metastasis. Surg Endosc. 2025. PMID: 40379853. doi:10.1007/s00464-025-11798-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。